Impact of SARS-CoV2 on youth onset type 2 diabetes new diagnoses and severity.
Impact of SARS-CoV2 on youth onset type 2 diabetes new diagnoses and severity.
复制标题
DOI:
10.1111/1753-0407.13301
复制
发表时间:
2022-08
影响因子:
4.5
通讯作者:
中科院分区:
文献类型:
--
作者:
Initial reports show an increase in youth onset type 2 diabetes during the COVID‐19 pandemic. We aim to expand on existing evidence by analyzing trends over a longer period. Our study aims to describe change in the amount, severity, and demographics of youth onset type 2 diabetes diagnoses during the COVID‐19 pandemic compared to the five years before. We performed a retrospective cross‐sectional review of youth (age ≤ 21) diagnosed with type 2 diabetes during the COVID‐19 pandemic (1 May 2020–30 April 2021) and the five years before (1 May 2015–30 April 2020) at a tertiary care center. Children were identified by International Classification of Diseases codes. Charts were reviewed to confirm diagnosis. Chi‐square, t tests, and Fisher's exact tests were used for analyses. In the prepandemic era annual diagnoses of type 2 diabetes ranged from 41–69 (mean = 54.2), whereas during the pandemic period 159 children were diagnosed, an increase of 293%. The increase resulted in a higher incidence rate ratio during the pandemic than before, 2.77 versus 1.07 (p = .006). New diagnoses increased most, by 490%, in Non‐Hispanic Black patients. The average HbA1c at presentation was higher during the pandemic (9.5% ± 2.6) (79.9 mmol/mol ± 28.2) than before (8.7%±2.1) (72.1 mmol/mol ± 23.1) (p = .003). Of those diagnosed during the pandemic, 59% were tested for COVID‐19 and three tested positive. New diagnoses of type 2 diabetes increased during the pandemic, most notably in Non‐Hispanic Black youth. There was not a significant correlation found with clinical or biochemical COVID‐19 infection in those tested. There has been an increase in new cases of youth onset type 2 diabetes during the pandemic. Non‐Hispanic Black youth have been most affected the increase in youth onset type 2 diabetes during the pandemic. No significant correlation was identified with clinical or biochemical COVID‐19 infection in those tested. Highlights
登录
查看更多内容
DOI:
10.1016/j.jand.2012.08.031
发表时间:
2012-12-01
影响因子:
4.8
作者:
Metallinos-Katsaras, Elizabeth;Must, Aviva;Gorman, Kathleen
通讯作者:
Gorman, Kathleen
影响因子:
6.9
作者:
von Hippel, Paul T.;Workman, Joseph
通讯作者:
Workman, Joseph
影响因子:
4.5
作者:
Chen TA;Baranowski T;Moreno JP;O'Connor TM;Hughes SO;Baranowski J;Woehler D;Kimbro RT;Johnston CA
通讯作者:
Johnston CA
影响因子:
7.3
作者:
Hamming, I;Timens, W;van Goor, H
通讯作者:
van Goor, H
影响因子:
16.2
作者:
Mayer-Davis EJ;Bell RA;Dabelea D;D'Agostino R Jr;Imperatore G;Lawrence JM;Liu L;Marcovina S;SEARCH for Diabetes in Youth Study Group
通讯作者:
SEARCH for Diabetes in Youth Study Group